Glenmede Trust’s Compugen CGEN Stock Holding History

Glenmede Trust’s Portfolio CGEN Stock Details CGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$73.5K	Buy	34,500 +22,500	+188%	+$43.7K	﹤0.01%	1409
2025 Q4	$18.4K	Buy	+12,000	New	+$19.9K	﹤0.01%	1412
2025 Q1	$17.5K	Sell	12,000 -15,500	-56%	-$30.3K	﹤0.01%	1345
2024 Q4	$42.1K	Hold	27,500	–	–	﹤0.01%	1336
2024 Q3	$49.8K	Hold	27,500	–	–	﹤0.01%	1321
2024 Q2	$46.2K	Hold	27,500	–	–	﹤0.01%	1284
2024 Q1	$71K	Hold	27,500	–	–	﹤0.01%	1248
2023 Q4	$54.5K	Hold	27,500	–	–	﹤0.01%	1224
2023 Q3	$25.6K	Hold	27,500	–	–	﹤0.01%	1202
2023 Q2	$19.3K	Hold	27,500	–	–	﹤0.01%	1235
2023 Q1	$19.3K	Hold	27,500	–	–	﹤0.01%	1241
2022 Q4	$19.7K	Buy	+27,500	New	+$24K	﹤0.01%	1236
2021 Q2	–	Sell	-19,000	Closed	-$163K	–	1274
2021 Q1	$163K	Hold	19,000	–	–	﹤0.01%	1074
2020 Q4	$230K	Hold	19,000	–	–	﹤0.01%	1025
2020 Q3	$308K	Hold	19,000	–	–	﹤0.01%	911
2020 Q2	$285K	Sell	19,000 -7,000	-27%	-$94.5K	﹤0.01%	924
2020 Q1	$154K	Hold	26,000	–	–	﹤0.01%	1283
2019 Q4	$154K	Hold	26,000	–	–	﹤0.01%	1283
2019 Q3	$109	Hold	26,000	–	–	﹤0.01%	1378
2019 Q2	$99	Hold	26,000	–	–	﹤0.01%	1406
2019 Q1	$107	Hold	26,000	–	–	﹤0.01%	1385
2018 Q4	$56	Hold	26,000	–	–	﹤0.01%	1541
2018 Q3	$100K	Sell	26,000 -10,000	-28%	-$35K	﹤0.01%	1293
2018 Q2	$119K	Buy	36,000 +14,000	+64%	+$52.6K	﹤0.01%	1214
2018 Q1	$55K	Hold	22,000	–	–	﹤0.01%	1585
2017 Q4	$55K	Hold	22,000	–	–	﹤0.01%	1585
2017 Q3	$83K	Hold	22,000	–	–	﹤0.01%	1469
2017 Q2	$94K	Hold	22,000	–	–	﹤0.01%	1402
2017 Q1	$94K	Buy	22,000 +7,000	+47%	+$32.3K	﹤0.01%	1402
2016 Q4	$76K	Buy	15,000 +5,001	+50%	+$29.9K	﹤0.01%	1475
2016 Q3	$62K	Hold	9,999	–	–	﹤0.01%	1544
2016 Q2	$64K	Hold	9,999	–	–	﹤0.01%	1484
2016 Q1	$55K	Hold	9,999	–	–	﹤0.01%	1490
2015 Q4	$63K	Sell	9,999 -1	-0%	-$7	﹤0.01%	1495
2015 Q3	$51K	Hold	10,000	–	–	﹤0.01%	1575
2015 Q2	$69K	Hold	10,000	–	–	﹤0.01%	1521
2015 Q1	$70K	Hold	10,000	–	–	﹤0.01%	1571
2014 Q4	$83K	Sell	10,000 -6,000	-38%	-$46.2K	﹤0.01%	1586
2014 Q3	$137K	Sell	16,000 -900	-5%	-$7.99K	﹤0.01%	1317
2014 Q2	$151K	Hold	16,900	–	–	﹤0.01%	1269
2014 Q1	$177K	Hold	16,900	–	–	﹤0.01%	1212
2013 Q4	$151K	Buy	16,900 +900	+6%	+$8.8K	﹤0.01%	1256
2013 Q3	$164K	Hold	16,000	–	–	﹤0.01%	1203
2013 Q2	$86K	Buy	+16,000	New	+$90.3K	﹤0.01%	1365

Other funds holding CGEN

SCM

Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM

TFCM

Taylor Frigon Capital Management Scottsdale, Arizona $176M AUM 24.25% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

YLHM

Yelin Lapidot Holdings Management Tel Aviv, Israel $480M AUM 42.17% 1-Year Est. Return

Glenmede Trust's CGEN Position: Q1 2026 in Review

Glenmede Trust increased its Compugen (CGEN) stake by 188% in Q1 2026, buying an estimated $43.7K and bringing the position to 34,500 shares worth $73.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1409.

Glenmede Trust first reported a position in CGEN in Q2 2013 and has held it in 44 quarters since. The position peaked at $308K in Q3 2020. 78 funds tracked by Wall St. Rank hold CGEN as of Q1 2026.

Glenmede Trust held 34,500 shares of Compugen worth $73.5K as of Q1 2026.
Glenmede Trust bought 22,500 Compugen shares in Q1 2026, an estimated $43.7K.
Compugen made up ﹤0.01% of Glenmede Trust's portfolio in Q1 2026, its #1409 holding.
Glenmede Trust first reported a position in Compugen in Q2 2013 and has held it in 44 quarters since.
Glenmede Trust's Compugen position peaked at $308K in Q3 2020.
78 funds tracked by Wall St. Rank held Compugen as of Q1 2026.

Based on Glenmede Trust's 13F filing for Q1 2026, filed 26 May 2026.